SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 4, 1996, Pages 403-407

Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck: A phase II Southwest Oncology Group study

(6) Smith, Roy E a Lew, Danika b Rodriguez, Gladys I c Taylor, Sarah A d Schuller, David e Ensley, John F f

a UNIVERSITY OF PITTSBURGH MEDICAL CENTER (United States)

b SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER (United States)

c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO (United States)

d UNIVERSITY OF KANSAS MEDICAL CENTER (United States)

e OHIO STATE UNIVERSITY (United States)

f WAYNE STATE UNIVERSITY (United States)

Author keywords

Head and neck cancer; Topoisomerase I inhibitor; Topotecan

Indexed keywords

TOPOTECAN;

ADULT; AGED; ALOPECIA; ANEMIA; ARTHRALGIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOTOXICITY; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DIARRHEA; DYSPNEA; FATIGUE; FEMALE; FEVER; GRANULOCYTOPENIA; HEAD AND NECK CANCER; HEADACHE; HUMAN; HYPONATREMIA; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; LEUKOPENIA; MALAISE; MALE; METASTASIS; MYALGIA; NAUSEA; NEUROTOXICITY; PAIN; PRIORITY JOURNAL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CARCINOMA, SQUAMOUS CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; TOPOTECAN;

EID: 0030465767 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (17)

References (7)

1
- 0026099599
- Synthesis of water-soluble (aminoalkyl) camptothecin analogues: Inhibition of topoisomerase I and antitumor activity
- Kingsbury WD, Boehm JC, Jakas DR, Holden KG, Hecht SM, Gallagher G, Caranfa MJ, McCabe FL, Faucette LF, Johnson RK: Synthesis of water-soluble (aminoalkyl) camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem 34(1):98-107, 1991
- (1991) J Med Chem , vol.34 , Issue.1 , pp. 98-107
- Kingsbury, W.D.¹ Boehm, J.C.² Jakas, D.R.³ Holden, K.G.⁴ Hecht, S.M.⁵ Gallagher, G.⁶ Caranfa, M.J.⁷ McCabe, F.L.⁸ Faucette, L.F.⁹ Johnson, R.K.¹⁰

2
- 0006095226
- Early clinical trials of topotecan, a new topoisomerase I inhibitor
- Burns H, Kuhn J, Wall J, Eckardt J, Rodriguez G, Johnson R, Weiss G, Shaffer D, van Hoff D: Early clinical trials of topotecan, a new topoisomerase I inhibitor (abstract). Ann Oncol 3(Suppl 1):118, 1992
- (1992) Ann Oncol , vol.3 , Issue.1 SUPPL. , pp. 118
- Burns, H.¹ Kuhn, J.² Wall, J.³ Eckardt, J.⁴ Rodriguez, G.⁵ Johnson, R.⁶ Weiss, G.⁷ Shaffer, D.⁸ Van Hoff, D.⁹

3
- 0010263172
- Phase I and pharmacologic study ot topotecan (SKF 104864): A novel topoisomerase 1 inhibitor
- Rowinsky E, Grochow L, Hendricks C, Sartorius S, Ettinger D, McGuire W, Forastiere A, Hurowitz L, Easter V, Donehower R: Phase I and pharmacologic study ot topotecan (SKF 104864): a novel topoisomerase 1 inhibitor (abstract). Proc Am Soc Clin Oncol 10:A240, 1991
- (1991) Proc Am Soc Clin Oncol , vol.10
- Rowinsky, E.¹ Grochow, L.² Hendricks, C.³ Sartorius, S.⁴ Ettinger, D.⁵ McGuire, W.⁶ Forastiere, A.⁷ Hurowitz, L.⁸ Easter, V.⁹ Donehower, R.¹⁰

4
- 0342964432
- Phase I trial of topotecan (SK&F 104864) in patients with refractory solid tumors
- Wall J, Burris H, Rodriquez G, Brown T, Weiss G, Kuhn J, Brown J, Johnson R, Friedman C, Mann W, van Hoff D: Phase I trial of topotecan (SK&F 104864) in patients with refractory solid tumors (abstract). Proc Annu Meet Am Soc Clin Oncol 10:A261, 1991
- (1991) Proc Annu Meet Am Soc Clin Oncol , vol.10
- Wall, J.¹ Burris, H.² Rodriquez, G.³ Brown, T.⁴ Weiss, G.⁵ Kuhn, J.⁶ Brown, J.⁷ Johnson, R.⁸ Friedman, C.⁹ Mann, W.¹⁰ Van Hoff, D.¹¹

5
- 0011909858
- A phase I trial of topotecan (TOPO) administered by a 24-hour infusion
- Recondo G, Abbruzzese J, Newman B, Newman R, Kuhn J, van Hoff D, Garteiz D, Raber M: A phase I trial of topotecan (TOPO) administered by a 24-hour infusion (abstract). Proc Am Assoc Cancer Res 32:A1229, 1991
- (1991) Proc Am Assoc Cancer Res , vol.32
- Recondo, G.¹ Abbruzzese, J.² Newman, B.³ Newman, R.⁴ Kuhn, J.⁵ Van Hoff, D.⁶ Garteiz, D.⁷ Raber, M.⁸

6
- 8544255607
- Phase II study of topotecan in advanced head and neck cancer: Identification of an active new agent
- Robert F, Wheeler RH, Molthrop DC, Greene P, Chen S : Phase II study of topotecan in advanced head and neck cancer: identification of an active new agent (abstract). Proc Annu Meet Am Soc Clin Oncol 13:A905, 1994
- (1994) Proc Annu Meet Am Soc Clin Oncol , vol.13
- Robert, F.¹ Wheeler, R.H.² Molthrop, D.C.³ Greene, P.⁴ Chen, S.⁵

7
- 25444495968
- Chemotherapy in recurrent and/or metastatic head and neck squamous cell carcinoma. Prognostic factors from 589 patients (pts) treated in three protocols
- Clavel M, Vermorken J, Cognetti F, deMulder P, Schornagel J, Verweij J, Kirkpatrick A, Dalesio O: Chemotherapy in recurrent and/or metastatic head and neck squamous cell carcinoma. Prognostic factors from 589 patients (pts) treated in three protocols (abstract). Proc Annu Meet Am Soc Clin Oncol 9:A692, 1990
- (1990) Proc Annu Meet Am Soc Clin Oncol , vol.9
- Clavel, M.¹ Vermorken, J.² Cognetti, F.³ Demulder, P.⁴ Schornagel, J.⁵ Verweij, J.⁶ Kirkpatrick, A.⁷ Dalesio, O.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.